Literature DB >> 27630310

Local Concentrations of CC-Chemokine-Ligand 18 Correlate with Tumor Size in Non-small Cell Lung Cancer and Are Elevated in Lymph Node-positive Disease.

Severin Schmid1, Uyen-Thao Le2, Benedikt Haager2, Olga Mayer2, Irene Dietrich3, Mirjam Elze2, Lars Johann Kemna3, Gernot Zissel4, Bernward Passlick2.   

Abstract

BACKGROUND: The tumor microenvironment plays a critical role in tumor growth and spreading. Tumor-associated macrophages (TAM) make up a large proportion of the tumor mass and are one of the main producers of CC-chemokine ligand 18 (CCL18), which is believed to carry out important functions in the immunological interactions that promote tumor progression.
MATERIALS AND METHODS: Cytokines/chemokines were measured in bronchoalveolar lavage (BAL) from the tumor site and serum before and after resection in patients with proven non-small cell lung cancer (NSCLC).
RESULTS: CCL18 concentrations in BAL positively correlated with the radiologically determined tumor volume (r=0.72, p=0.0003) in NSCLC. In addition, tumors with lymph-node metastasis exhibited significantly higher CCL18 concentrations in BAL (p=0.049) than those without. Serum CCL18 concentrations did not differ significantly before and after tumor resection.
CONCLUSION: The increased release of CCL18 with greater tumor size is most likely due to the accompanied growth of leukocyte infiltrate. With previous findings taken into account, this could be one factor contributing to tumor invasiveness and particularly lymphatic spread in patients with larger tumors. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  CCL18; TAM; lymphatic spread; tumor associated macrophages; tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27630310     DOI: 10.21873/anticanres.11018

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.

Authors:  Noriyuki Hirahara; Yoshitsugu Tajima; Yusuke Fujii; Tetsu Yamamoto; Ryoji Hyakudomi; Takanori Hirayama; Takahito Taniura; Kazunari Ishitobi; Akihiko Kidani; Yasunari Kawabata
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

2.  Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

Authors:  Eleni Gkika; Werner Vach; Sonja Adebahr; Tanja Schimek-Jasch; Anton Brenner; Thomas Baptist Brunner; Klaus Kaier; Antje Prasse; Joachim Müller-Quernheim; Anca-Ligia Grosu; Gernot Zissel; Ursula Nestle
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

3.  CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway.

Authors:  Yuexiang Qin; Juncheng Wang; Gangcai Zhu; Guo Li; Haolei Tan; Changhan Chen; Leiming Pi; Li She; Xiyu Chen; Ming Wei; Zhexuan Li; Zhifeng Liu; Donghai Huang; Yong Liu; Xin Zhang
Journal:  J Cell Mol Med       Date:  2019-02-15       Impact factor: 5.310

4.  A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development.

Authors:  Eda G Ramirez-Valles; Alicia Rodríguez-Pulido; Marcelo Barraza-Salas; Isaac Martínez-Velis; Iván Meneses-Morales; Víctor M Ayala-García; Carlos A Alba-Fierro
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 5.  CCL18 in the Progression of Cancer.

Authors:  Jan Korbecki; Mateusz Olbromski; Piotr Dzięgiel
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.